Dataset of potential Rhizoma Polygonati compound-druggable targets and partial pharmacokinetics for treatment of COVID-19
Chenglin Mu,
Yifan Sheng,
Qian Wang,
Amr Amin,
Xugang Li,
Yingqiu Xie
Affiliations
Chenglin Mu
State Key Laboratory of Crop Biology, College of Life Sciences, Shandong Agricultural University, Daizong Street 61, Tai'an, 271018, China; Sino German Joint Research Center for Agricultural Biology, College of Life Sciences, Shandong Agricultural University, Daizong Street 61, Tai'an, 271018, China
Yifan Sheng
College of Life Science, Northeast Agricultural University, Harbin, 150030, China
Qian Wang
Tai'an Xianlu Food Co. Ltd., Tai'an, China
Amr Amin
Biology Department, UAE University, Al Ain 15551, UAE
Xugang Li
State Key Laboratory of Crop Biology, College of Life Sciences, Shandong Agricultural University, Daizong Street 61, Tai'an, 271018, China; Sino German Joint Research Center for Agricultural Biology, College of Life Sciences, Shandong Agricultural University, Daizong Street 61, Tai'an, 271018, China; Corresponding authors.
Yingqiu Xie
Department of Biology, School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, 010000, Republic of Kazakhstan; Corresponding authors.
Rhizoma Polygonati (Chinese name as 黄精, pinyin as huangjing), as medicine and food homology of Traditional Chinese Medicine, has been recently applied for the complex prescriptions of alternative medicine for treatment of COVID-19 but the mechanisms are largely unclear. Here using public database search and filtering the potential chemical compound based drug targets with COVID-19 targets mapped, the list of data were provided and suggested pharmacokinetic tolerating dose of selected natural compounds were further collected from database. The data provided is the supplementary as a reference showing the intersections of Rhizoma Polygonati druggable targets of lists from current database and potentially related ones targeting COVID-19.
